Oseltamivir analogues bearing N-substituted guanidines as potent neuraminidase inhibitors

Files

Access status: Embargo until 2050-01-01 , moret_oseltamivir_2014.pdf (3.63 MB)

Publication date

2014-04-10

Authors

Mooney, Caitlin A.
Johnson, Stuart A.
't Hart, P.ISNI 0000000493280733
van Ufford, Linda QuarlesISNI 0000000389772666
de Haan, XanderORCID 0000-0002-4459-9874ISNI 0000000395765470
Moret, Ed EISNI 0000000369314238
Martin, NathanielISNI 0000000419429800

Editors

Advisors

Supervisors

Document Type

Article

License

Abstract

A series of oseltamivir analogues bearing an N-substituted guanidine unit were prepared and evaluated as inhibitors of neuraminidases from four strains of influenza the two most potent analogues identified contain relatively small N-guanidine substituents (N-methyl and N-hydroxyl) and display enhanced inhibition with IC50 values in the low nanomolar range against neuraminidases from wild-type and oseltamivir-resistant strains. Potential advantages of including the N-hydroxyguanidine moiety in neuraminidase inhibitors are also discussed.

Keywords

Molecular Medicine, Drug Discovery

Citation

Mooney, C A, Johnson, S A, 'T Hart, P, Quarles Van Ufford, L, De Haan, C A M, Moret, E E & Martin, N I 2014, 'Oseltamivir analogues bearing N-substituted guanidines as potent neuraminidase inhibitors', Journal of Medicinal Chemistry, vol. 57, no. 7, pp. 3154-3160. https://doi.org/10.1021/jm401977j